These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2207356)

  • 1. [Possible value of variations in the serum alkaline DNAse activity in the prognosis of cancers of the upper respiratory-digestive tract treated by chemotherapy].
    Roullet B; Labadie M; Taper H; Lans M; Economidou-Karaoglou A; Dewez B; Roberfroid M; Berdah JF; Bachellerie-Rhein B; Clavere P
    Bull Cancer; 1990; 77(7):675-80. PubMed ID: 2207356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations in serum alkaline DNase activity: a possible clinical test for therapeutic prognosis of human tumors.
    Taper H; Lans M; Economidou-Karaoglou A; de Gerlache J; Roberfroid M
    Anticancer Res; 1986; 6(5):949-56. PubMed ID: 3467649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
    Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
    Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck.
    Argiris A; Li Y; Forastiere A
    Cancer; 2004 Nov; 101(10):2222-9. PubMed ID: 15452834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
    Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM
    Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of serum alkaline DNase activity in treatment monitoring of head and neck cancer patients.
    Patel PS; Patel BP; Rawal RM; Raval GN; Patel MM; Patel JB; Jha FP; Patel DD
    Tumour Biol; 2000; 21(2):82-9. PubMed ID: 10686537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
    Worden FP; Moon J; Samlowski W; Clark JI; Dakhil SR; Williamson S; Urba SG; Ensley J; Hussain MH;
    Cancer; 2006 Jul; 107(2):319-27. PubMed ID: 16779801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer.
    Shiga H; Heath EI; Rasmussen AA; Trock B; Johnston PG; Forastiere AA; Langmacher M; Baylor A; Lee M; Cullen KJ
    Clin Cancer Res; 1999 Dec; 5(12):4097-104. PubMed ID: 10632346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of reoxygenation in advanced cancer of the head and neck during the initial course of chemoradiation or radiotherapy alone.
    Dietz A; Vanselow B; Rudat V; Conradt C; Weidauer H; Kallinowski F; Dollner R
    Head Neck; 2003 Jan; 25(1):50-8. PubMed ID: 12478544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
    Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction paclitaxel and carboplatin for patients with head and neck carcinoma. Analysis of 62 patients treated between 1994 an 1999.
    Dunphy FR; Dunleavy TL; Harrison BR; Trinkaus KM; Kim HJ; Stack BC; Needles B; Boyd JH
    Cancer; 2001 Mar; 91(5):940-8. PubMed ID: 11251945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy.
    Hitt R; Ciruelos E; Amador ML; Benito A; Sanchez JJ; Ballestin C; Cortes-Funes H
    Eur J Cancer; 2005 Feb; 41(3):453-60. PubMed ID: 15691646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer.
    Caponigro F; Avallone A; McLeod H; Cartenì G; De Vita F; Casaretti R; Morsman J; Blackie R; Budillon A; De Lucia L; Gravina A; Catalano G; Comella P; Comella G
    Clin Cancer Res; 1999 Dec; 5(12):3948-55. PubMed ID: 10632324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group.
    Gibson MK; Li Y; Murphy B; Hussain MH; DeConti RC; Ensley J; Forastiere AA;
    J Clin Oncol; 2005 May; 23(15):3562-7. PubMed ID: 15908667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Ginsberg L; Lawhorn K; Hong WK; Lippman SM
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous cisplatin and 5-fluorouracil as second-line treatment of head and neck cancer.
    Merlano M; Grimaldi A; Brunetti I; Modenesi M; Scala M; Margarino G; Scasso F; Santelli A; Castiglia G; Pallestrini E
    Cancer Treat Rep; 1987 May; 71(5):485-8. PubMed ID: 3567974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neoadjuvant treatment with cisplatin, 5-FU and folinic acid in advanced head and neck cancer].
    Contreras J; Medina JA; Albero A; Herruzo I; Marina E; Azcoaga JM; Bretón JJ
    Acta Otorrinolaringol Esp; 1994; 45(2):87-91. PubMed ID: 8086215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of unknown primary squamous cell carcinoma in the neck showing a high response with combined chemotherapy including nedaplatin, adriamycin and 5-fluorouracil].
    Yamashita S; Hirao M; Tsujinaka T; Sawamura T; Nakamori S; Mishima H; Fujitani K; Ikenaga M; Kashiwazaki M; Masuda N
    Gan To Kagaku Ryoho; 2005 Aug; 32(8):1149-51. PubMed ID: 16121918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of methotrexate and cisplatin for patients with advanced squamous cell carcinoma of the head and neck region: a Southwest Oncology Group Study.
    Grose WE; Lehane DE; Dixon DO; Fletcher WS; Stuckey WJ
    Cancer Treat Rep; 1985 Jun; 69(6):577-81. PubMed ID: 4040421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.